Ascelia Pharma AB Balance Sheet

Financials in millions SEK. Fiscal year is January - December.

Millions SEK. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	33.89	49.86	75.26	21.86	149.56	261.6
Cash & Short-Term Investments	33.89	49.86	75.26	21.86	149.56	261.6
Cash Growth	-40.86%	-33.75%	244.34%	-85.39%	-42.83%	41.64%
Other Receivables	3.76	3.3	6.1	2.99	5.16	5.87
Receivables	3.76	3.3	6.1	2.99	5.16	5.87
Prepaid Expenses	1.33	0.63	0.61	0.66	0.79	0.96
Other Current Assets	0.15	0.15	1.75	3.43	5.36	6.18
Total Current Assets	39.12	53.94	83.72	28.94	160.87	274.61
Property, Plant & Equipment	0.68	0.94	0.12	1.06	0.63	1.82
Other Intangible Assets	57.07	57.07	57.08	57.07	57.07	57.06
Other Long-Term Assets	-	-0	-	-0	0	-
Total Assets	96.87	111.94	140.92	87.07	218.57	333.49
Accounts Payable	3.49	2.04	4.73	1.53	15.88	6.15
Accrued Expenses	8.73	8.48	12.73	8.52	19.66	16.34
Short-Term Debt	-	-	25.23	-	-	-
Current Portion of Leases	0.69	0.9	0.17	0.88	0.29	1.1
Current Income Taxes Payable	-	-	-	-	-	0.01
Other Current Liabilities	1.04	0.97	19.11	1.64	1.69	1.51
Total Current Liabilities	13.95	12.4	61.98	12.57	37.52	25.11
Long-Term Leases	-	0.07	-	0.18	0.19	0.55
Other Long-Term Liabilities	-0	-	-	-	-0	-
Total Liabilities	13.95	12.47	61.98	12.74	37.71	25.66
Common Stock	127.9	127.9	97.19	34.87	34.87	34.58
Additional Paid-In Capital	771.37	771.37	721.75	678.75	678.75	678.83
Retained Earnings	-817.36	-800.9	-740.97	-639.96	-533.73	-405.83
Comprehensive Income & Other	1.02	1.11	0.97	0.67	0.97	0.25
Shareholders' Equity	82.92	99.47	78.94	74.33	180.86	307.83
Total Liabilities & Equity	96.87	111.94	140.92	87.07	218.57	333.49
Total Debt	0.69	0.97	25.4	1.06	0.48	1.66
Net Cash (Debt)	33.2	48.89	49.86	20.8	149.07	259.94
Net Cash Growth	10.44%	-1.94%	139.76%	-86.05%	-42.65%	42.12%
Net Cash Per Share	0.27	0.43	0.92	0.62	4.28	7.89
Filing Date Shares Outstanding	126.87	126.87	96.11	33.76	33.67	33.67
Total Common Shares Outstanding	126.87	126.87	96.11	33.76	33.67	33.67
Working Capital	25.17	41.54	21.74	16.37	123.35	249.51
Book Value Per Share	0.65	0.78	0.82	2.20	5.37	9.14
Tangible Book Value	25.85	42.4	21.87	17.25	123.79	250.77
Tangible Book Value Per Share	0.20	0.33	0.23	0.51	3.68	7.45
Machinery	-	0.66	0.6	0.6	0.6	0.6

Source: S&P Global Market Intelligence. Standard template. Financial Sources.